Researchers have used a personalised base-editing gene therapy to successfully treat an infant with carbamoyl-phosphate ...

After 3 doses of tailor-made treatment, an infant with a rare, life-threatening urea cycle disorder is thriving ...

A tailored CRISPR base-editing therapy was given for the first time to an infant who was born with a rare genetic disease, with promising effects, researchers reported.